T2	KeyEntity 163 169	kidney
T3	KeyEntity 185 190	urine
T4	KeyEntity 206 217	vasopressin
R1	participates_in Arg1:T4 Arg2:T2	
T5	KeyEntity 239 269	nephrogenic diabetes insipidus
T6	Entity 296 305	mutations
T7	KeyEntity 313 343	vasopressin receptor 2 (Avpr2)
T8	KeyEntity 392 410	aquaporin-2 (Aqp2)
T9	Entity 494 506	animal model
T10	KeyEntity 516 541	forward genetic screening
T11	KeyEntity 545 573	ethylnitrosourea-mutagenized
T12	Entity 635 646	mouse model
T1	KeyEntity 70 117	Congenital nephrogenic diabetes insipidus (NDI)
T13	KeyEntity 650 654	NDI,
T14	KeyEntity 663 677	F204V mutation
T15	KeyEntity 685 689	Aqp2
R2	other_relation Arg1:T14 Arg2:T13	
#1	AnnotatorNotes R2	causes phenotype
T16	KeyEntity 741 744	NDI
T17	Entity 724 737	murine models
T18	Entity 766 775	adulthood
T19	Entity 810 824	human disorder
T20	KeyEntity 793 805	recapitulate
T21	Entity 835 843	in vitro
T22	KeyEntity 862 878	renal cell lines
T23	KeyEntity 897 901	Aqp2
T24	Entity 922 942	improper trafficking
T25	Entity 902 911	mutations
T26	Entity 897 911	Aqp2 mutations
R3	other_relation Arg1:T26 Arg2:T24	
#2	AnnotatorNotes R3	results in
T27	KeyEntity 1033 1060	improper AQP2 translocation
T28	Entity 1068 1084	molecular defect
T29	KeyEntity 1088 1118	nephrogenic diabetes insipidus
R4	other_relation Arg1:T27 Arg2:T29	
#3	AnnotatorNotes R4	causes phenotype
T30	KeyEntity 1165 1180	renal cell line
T31	KeyEntity 1215 1225	AQP2-F204V
T32	KeyEntity 1246 1267	endoplasmic reticulum
T33	KeyEntity 1282 1303	abnormal localization
T34	KeyEntity 1311 1318	rescued
T35	KeyEntity 1322 1339	wild-type protein
R5	other_relation Arg1:T35 Arg2:T33	
#4	AnnotatorNotes R5	rescues
T36	Entity 1352 1363	mouse model
T37	Entity 1383 1402	mechanistic studies
T38	Entity 1425 1440	pharmacological
T39	Entity 1445 1459	gene therapies
T40	KeyEntity 1464 1467	NDI
